Nalaganje...
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
BACKGROUND: Interleukin-11 (IL-11), a dominant IL-6 family cytokine, is involved in tumorigenesis, tumor progression and differentiation in colon cancer cells. IL-11 signaling has been recently identified as a potential therapeutic target in colon cancer. Bazedoxifene, a third- generation selective...
Shranjeno v:
| izdano v: | J Exp Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368818/ https://ncbi.nlm.nih.gov/pubmed/30736824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1072-8 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|